| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,515 |
12,626 |
$1.09M |
| 99199 |
Unlisted special service, procedure or report |
54,366 |
32,193 |
$329K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,832 |
4,541 |
$297K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,915 |
2,495 |
$43K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
331 |
282 |
$35K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
348 |
216 |
$24K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,451 |
1,592 |
$22K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
275 |
181 |
$18K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
518 |
355 |
$14K |
| 81002 |
|
6,066 |
4,582 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
7,145 |
5,349 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
244 |
205 |
$10K |
| 93000 |
|
1,021 |
754 |
$9K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
120 |
82 |
$8K |
| 82962 |
|
5,353 |
3,757 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
448 |
323 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
52 |
49 |
$5K |
| 90688 |
|
1,074 |
671 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
173 |
142 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
377 |
185 |
$4K |
| 90756 |
|
402 |
250 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
255 |
201 |
$3K |
| 0053A |
|
40 |
28 |
$2K |
| 0003A |
|
60 |
44 |
$2K |
| 81025 |
|
328 |
228 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
23 |
18 |
$1K |
| 0001A |
|
48 |
26 |
$1K |
| 90686 |
|
1,318 |
934 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
23 |
12 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
53 |
35 |
$1K |
| 90734 |
|
15 |
12 |
$762.20 |
| 86328 |
|
13 |
13 |
$542.76 |
| 90658 |
|
128 |
87 |
$229.47 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
35 |
23 |
$203.49 |
| 0054A |
|
19 |
13 |
$195.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
226 |
167 |
$144.32 |
| 82043 |
|
19 |
13 |
$53.84 |
| 82570 |
|
14 |
12 |
$38.92 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
115 |
97 |
$22.72 |
| 91300 |
|
362 |
211 |
$0.01 |
| 90662 |
|
32 |
27 |
$0.00 |
| 3077F |
|
461 |
335 |
$0.00 |
| 3078F |
|
363 |
286 |
$0.00 |
| 99072 |
|
111 |
86 |
$0.00 |
| 90649 |
|
82 |
53 |
$0.00 |
| 3074F |
|
232 |
186 |
$0.00 |
| 3079F |
|
239 |
193 |
$0.00 |
| 99000 |
|
56 |
44 |
$0.00 |
| 3075F |
|
127 |
108 |
$0.00 |
| 3080F |
|
188 |
140 |
$0.00 |
| 3044F |
|
151 |
127 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
205 |
143 |
$0.00 |
| 91305 |
|
23 |
18 |
$0.00 |